177Lu-girentuximab + Cabozantinib + Nivolumab
|
177Lu-girentuximab
Cabozantinib
Nivolumab
|
0 |
1 |
177Lu-girentuximab + Nivolumab
|
177Lu-girentuximab
Nivolumab
|
0 |
1 |
7HP349 + Ipilimumab + Nivolumab
|
7HP349
Ipilimumab
Nivolumab
|
0 |
1 |
AB521 + Nivolumab + XL092
|
AB521
Nivolumab
XL092
|
0 |
1 |
ABBV-368 + Nivolumab
|
ABBV-368
Nivolumab
|
0 |
1 |
ABBV-428 + Nivolumab
|
ABBV-428
Nivolumab
|
0 |
1 |
ABBV-927 + Nivolumab
|
ABBV-927
Nivolumab
|
0 |
1 |
Abemaciclib + Anastrozole + Nivolumab
|
Abemaciclib
Anastrozole
Nivolumab
|
0 |
0 |
Abemaciclib + Nivolumab
|
Abemaciclib
Nivolumab
|
0 |
3 |
Abiraterone + Cabozantinib + Nivolumab + Prednisone
|
Abiraterone
Cabozantinib
Nivolumab
Prednisone
|
0 |
1 |
ABX196 + Nivolumab
|
ABX196
Nivolumab
|
0 |
1 |
Ad-RTS-IL-12 plus AL + Nivolumab
|
Ad-RTS-IL-12 plus AL
Nivolumab
|
0 |
1 |
Ad.p53-DC vaccine + Ipilimumab + Nivolumab
|
Ad.p53-DC vaccine
Ipilimumab
Nivolumab
|
0 |
1 |
Ad5CMV-p53 gene + Nivolumab
|
Ad5CMV-p53 gene
Nivolumab
|
0 |
2 |
Adagrasib + Nivolumab
|
Adagrasib
Nivolumab
|
0 |
1 |
ADI-PEG 20 + Ipilimumab + Nivolumab
|
ADI-PEG 20
Ipilimumab
Nivolumab
|
0 |
1 |
ADI-PEG 20 + Nivolumab
|
ADI-PEG 20
Nivolumab
|
0 |
1 |
Ado-trastuzumab emtansine + Nivolumab
|
Ado-trastuzumab emtansine
Nivolumab
|
0 |
0 |
ADP-A2M4CD8 + Nivolumab
|
ADP-A2M4CD8
Nivolumab
|
0 |
0 |
AdV-tk + Nivolumab
|
AdV-tk
Nivolumab
|
0 |
1 |
afamitresgene autoleucel + Nivolumab
|
Nivolumab
afamitresgene autoleucel
|
0 |
1 |
Afatinib + Nivolumab
|
Afatinib
Nivolumab
|
0 |
1 |
AGEN1777 + Carboplatin + Nivolumab + Paclitaxel
|
AGEN1777
Carboplatin
Nivolumab
Paclitaxel
|
0 |
1 |
AGEN1777 + Carboplatin + Nivolumab + Pemetrexed Disodium
|
AGEN1777
Carboplatin
Nivolumab
Pemetrexed Disodium
|
0 |
1 |
AGEN1777 + Docetaxel + Nivolumab
|
AGEN1777
Docetaxel
Nivolumab
|
0 |
1 |
AGEN1777 + Nivolumab
|
AGEN1777
Nivolumab
|
0 |
1 |
AgenT-797 + Nivolumab
|
AgenT-797
Nivolumab
|
0 |
1 |
Aldesleukin + Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin
|
Aldesleukin
Fluorouracil
Leucovorin
Nivolumab
Oxaliplatin
|
0 |
1 |
Aldesleukin + Ipilimumab + Nivolumab
|
Aldesleukin
Ipilimumab
Nivolumab
|
0 |
1 |
Aldesleukin + Nivolumab
|
Aldesleukin
Nivolumab
|
0 |
2 |
Aldesleukin + Nivolumab + tumor infiltrating lymphocytes
|
Aldesleukin
Nivolumab
tumor infiltrating lymphocytes
|
0 |
1 |
Allocetra-OTS + Nivolumab
|
Allocetra-OTS
Nivolumab
|
0 |
1 |
Anastrozole + Nivolumab + Palbociclib
|
Anastrozole
Nivolumab
Palbociclib
|
0 |
1 |
Andecaliximab + Nivolumab
|
Andecaliximab
Nivolumab
|
0 |
1 |
Anetumab ravtansine + Gemcitabine + Nivolumab
|
Anetumab ravtansine
Gemcitabine
Nivolumab
|
0 |
1 |
Anetumab ravtansine + Ipilimumab + Nivolumab
|
Anetumab ravtansine
Ipilimumab
Nivolumab
|
0 |
1 |
Anetumab ravtansine + Nivolumab
|
Anetumab ravtansine
Nivolumab
|
0 |
1 |
Anlotinib + Nivolumab
|
Anlotinib
Nivolumab
|
0 |
1 |
Anlotinib + Nivolumab + Pyrotinib
|
Anlotinib
Nivolumab
Pyrotinib
|
0 |
0 |
Anthracycline + Cyclophosphamide + Nivolumab
|
Anthracycline
Cyclophosphamide
Nivolumab
|
0 |
1 |
Anti-IL13RA2 CAR-T cells + Ipilimumab + Nivolumab
|
Anti-IL13RA2 CAR-T cells
Ipilimumab
Nivolumab
|
0 |
1 |
Anti-IL13RA2 CAR-T cells + Nivolumab
|
Anti-IL13RA2 CAR-T cells
Nivolumab
|
0 |
1 |
ANV419 + Nivolumab
|
ANV419
Nivolumab
|
0 |
0 |
Ascrinvacumab + Nivolumab
|
Ascrinvacumab
Nivolumab
|
0 |
1 |
ASP1948 + Nivolumab
|
ASP1948
Nivolumab
|
0 |
1 |
Atezolizumab + Avelumab + Durvalumab + Nivolumab + Pembrolizumab
|
Atezolizumab
Avelumab
Durvalumab
Nivolumab
Pembrolizumab
|
0 |
1 |
Atezolizumab + Avelumab + Durvalumab + Nivolumab + Pembrolizumab + Plinabulin
|
Atezolizumab
Avelumab
Durvalumab
Nivolumab
Pembrolizumab
Plinabulin
|
0 |
1 |
ATL001 + Nivolumab
|
ATL001
Nivolumab
|
0 |
1 |
ATLCAR.CD30 cells + Nivolumab
|
ATLCAR.CD30 cells
Nivolumab
|
0 |
1 |
Autogene cevumeran + Nivolumab
|
Autogene cevumeran
Nivolumab
|
0 |
1 |
Axatilimab + Nivolumab
|
Axatilimab
Nivolumab
|
0 |
1 |
Axitinib + Ipilimumab + Nivolumab
|
Axitinib
Ipilimumab
Nivolumab
|
0 |
1 |
Axitinib + Nivolumab
|
Axitinib
Nivolumab
|
0 |
6 |
Axitinib + Nivolumab + NKTR-214
|
Axitinib
NKTR-214
Nivolumab
|
0 |
1 |
Azacitidine + Nivolumab
|
Azacitidine
Nivolumab
|
0 |
7 |
Azacitidine + Nivolumab + Relatlimab
|
Azacitidine
Nivolumab
Relatlimab
|
0 |
1 |
BA3071 + Nivolumab
|
BA3071
Nivolumab
|
0 |
1 |
BBP-398 + Nivolumab
|
BBP-398
Nivolumab
|
0 |
1 |
BCG solution + Linrodostat + Nivolumab
|
BCG solution
Linrodostat
Nivolumab
|
0 |
1 |
BCG solution + Nivolumab
|
BCG solution
Nivolumab
|
0 |
2 |
BDC-1001 + Nivolumab
|
BDC-1001
Nivolumab
|
0 |
0 |
Belvarafenib + Cobimetinib + Nivolumab
|
Belvarafenib
Cobimetinib
Nivolumab
|
0 |
1 |
Bemarituzumab + Capecitabine + Nivolumab + Oxaliplatin
|
Bemarituzumab
Capecitabine
Nivolumab
Oxaliplatin
|
0 |
1 |
Bemarituzumab + Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin
|
Bemarituzumab
Fluorouracil
Leucovorin
Nivolumab
Oxaliplatin
|
0 |
1 |
Bemarituzumab + Nivolumab + Oxaliplatin + Tegafur-gimeracil-oteracil Potassium
|
Bemarituzumab
Nivolumab
Oxaliplatin
Tegafur-gimeracil-oteracil Potassium
|
0 |
1 |
Bendamustine + Gemcitabine + Nivolumab
|
Bendamustine
Gemcitabine
Nivolumab
|
0 |
1 |
Bevacizumab + EO2401 + Nivolumab
|
Bevacizumab
EO2401
Nivolumab
|
0 |
0 |
Bevacizumab + Fluorouracil + Irinotecan + Leucovorin + Nivolumab + Oxaliplatin
|
Bevacizumab
Fluorouracil
Irinotecan
Leucovorin
Nivolumab
Oxaliplatin
|
0 |
1 |
Bevacizumab + Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin
|
Bevacizumab
Fluorouracil
Leucovorin
Nivolumab
Oxaliplatin
|
0 |
1 |
Bevacizumab + Nivolumab
|
Bevacizumab
Nivolumab
|
0 |
6 |
Bevacizumab + Nivolumab + Relatlimab
|
Bevacizumab
Nivolumab
Relatlimab
|
0 |
1 |
Bicalutamide + Ipilimumab + Nivolumab
|
Bicalutamide
Ipilimumab
Nivolumab
|
0 |
1 |
Binimetinib + Encorafenib + Ipilimumab + Nivolumab
|
Binimetinib
Encorafenib
Ipilimumab
Nivolumab
|
0 |
1 |
Binimetinib + Encorafenib + Nivolumab
|
Binimetinib
Encorafenib
Nivolumab
|
0 |
4 |
Binimetinib + Encorafenib + Nivolumab + Temozolomide
|
Binimetinib
Encorafenib
Nivolumab
Temozolomide
|
0 |
0 |
Binimetinib + Ipilimumab + Nivolumab
|
Binimetinib
Ipilimumab
Nivolumab
|
0 |
1 |
Binimetinib + Nivolumab
|
Binimetinib
Nivolumab
|
0 |
2 |
Bleomycin + Brentuximab vedotin + Dacarbazine + Doxorubicin + Nivolumab + Vinblastine
|
Bleomycin
Brentuximab vedotin
Dacarbazine
Doxorubicin
Nivolumab
Vinblastine
|
0 |
1 |
Bleomycin + Dacarbazine + Doxorubicin + Nivolumab + Vinblastine
|
Bleomycin
Dacarbazine
Doxorubicin
Nivolumab
Vinblastine
|
0 |
1 |
Blinatumomab + Cytarabine + Dexamethasone + Hydrocortisone Sodium Succinate + Leucovorin + Methotrexate + Nivolumab
|
Blinatumomab
Cytarabine
Dexamethasone
Hydrocortisone Sodium Succinate
Leucovorin
Methotrexate
Nivolumab
|
0 |
1 |
Blinatumomab + Cytarabine + Dexamethasone + Hydrocortisone Sodium Succinate + Methotrexate + Nivolumab
|
Blinatumomab
Cytarabine
Dexamethasone
Hydrocortisone Sodium Succinate
Methotrexate
Nivolumab
|
0 |
1 |
Blinatumomab + Cytarabine + Dexamethasone + Leucovorin + Methotrexate + Nivolumab
|
Blinatumomab
Cytarabine
Dexamethasone
Leucovorin
Methotrexate
Nivolumab
|
0 |
0 |
Blinatumomab + Cytarabine + Dexamethasone + Methotrexate + Nivolumab
|
Blinatumomab
Cytarabine
Dexamethasone
Methotrexate
Nivolumab
|
0 |
0 |
Blinatumomab + Dexamethasone + Methotrexate + Nivolumab
|
Blinatumomab
Dexamethasone
Methotrexate
Nivolumab
|
0 |
1 |
Blinatumomab + Ipilimumab + Nivolumab
|
Blinatumomab
Ipilimumab
Nivolumab
|
0 |
1 |
Blinatumomab + Methotrexate + Nivolumab
|
Blinatumomab
Methotrexate
Nivolumab
|
0 |
1 |
BMS-813160 + Gemcitabine + Nab-paclitaxel + Nivolumab
|
BMS-813160
Gemcitabine
Nab-paclitaxel
Nivolumab
|
0 |
1 |
BMS-813160 + GVAX pancreatic cancer vaccine + Nivolumab
|
BMS-813160
GVAX pancreatic cancer vaccine
Nivolumab
|
0 |
1 |
BMS-813160 + Nivolumab
|
BMS-813160
Nivolumab
|
0 |
3 |
BMS-986012 + Carboplatin + Etoposide + Nivolumab
|
BMS-986012
Carboplatin
Etoposide
Nivolumab
|
0 |
1 |
BMS-986012 + Nivolumab
|
BMS-986012
Nivolumab
|
0 |
1 |
BMS-986148 + Nivolumab
|
BMS-986148
Nivolumab
|
0 |
1 |
BMS-986156 + Ipilimumab + Nivolumab
|
BMS-986156
Ipilimumab
Nivolumab
|
0 |
1 |
BMS-986156 + Nivolumab
|
BMS-986156
Nivolumab
|
0 |
2 |
BMS-986178 + Ipilimumab + Nivolumab
|
BMS-986178
Ipilimumab
Nivolumab
|
0 |
0 |
BMS-986178 + Nivolumab
|
BMS-986178
Nivolumab
|
0 |
0 |
BMS-986179 + Nivolumab
|
BMS-986179
Nivolumab
|
0 |
1 |
BMS-986183 + Nivolumab
|
BMS-986183
Nivolumab
|
0 |
1 |
BMS-986207 + COM701 + Nivolumab
|
BMS-986207
COM701
Nivolumab
|
0 |
1 |
BMS-986207 + Ipilimumab + Nivolumab
|
BMS-986207
Ipilimumab
Nivolumab
|
0 |
1 |
BMS-986207 + Nivolumab
|
BMS-986207
Nivolumab
|
0 |
1 |
BMS-986218 + Docetaxel + Nivolumab
|
BMS-986218
Docetaxel
Nivolumab
|
0 |
1 |
BMS-986218 + Nivolumab
|
BMS-986218
Nivolumab
|
0 |
3 |
BMS-986226 + Nivolumab
|
BMS-986226
Nivolumab
|
0 |
1 |
BMS-986242 + Nivolumab
|
BMS-986242
Nivolumab
|
0 |
1 |
BMS-986249 + Nivolumab
|
BMS-986249
Nivolumab
|
0 |
1 |
BMS-986253 + Degarelix + Nivolumab
|
BMS-986253
Degarelix
Nivolumab
|
0 |
1 |
BMS-986253 + Nivolumab
|
BMS-986253
Nivolumab
|
0 |
6 |
BMS-986258 + Nivolumab
|
BMS-986258
Nivolumab
|
0 |
1 |
BMS-986277 + Nivolumab
|
BMS-986277
Nivolumab
|
0 |
1 |
BMS-986288 + Nivolumab
|
BMS-986288
Nivolumab
|
0 |
1 |
BMS-986299 + Ipilimumab + Nivolumab
|
BMS-986299
Ipilimumab
Nivolumab
|
0 |
1 |
BMS-986310 + Nivolumab
|
BMS-986310
Nivolumab
|
0 |
1 |
BMS-986315 + Carboplatin + Cisplatin + Nivolumab + Paclitaxel + Pemetrexed Disodium
|
BMS-986315
Carboplatin
Cisplatin
Nivolumab
Paclitaxel
Pemetrexed Disodium
|
0 |
0 |
BMS-986315 + Carboplatin + Nivolumab + Paclitaxel
|
BMS-986315
Carboplatin
Nivolumab
Paclitaxel
|
0 |
1 |
BMS-986315 + Carboplatin + Nivolumab + Pemetrexed Disodium
|
BMS-986315
Carboplatin
Nivolumab
Pemetrexed Disodium
|
0 |
1 |
BMS-986315 + Cisplatin + Nivolumab + Pemetrexed Disodium
|
BMS-986315
Cisplatin
Nivolumab
Pemetrexed Disodium
|
0 |
1 |
BMS-986315 + Nivolumab
|
BMS-986315
Nivolumab
|
0 |
1 |
BMS-986340 + Nivolumab
|
BMS-986340
Nivolumab
|
0 |
1 |
BMS-986406 + Nivolumab
|
BMS-986406
Nivolumab
|
0 |
1 |
BMS-986408 + Ipilimumab + Nivolumab
|
BMS-986408
Ipilimumab
Nivolumab
|
0 |
1 |
BMS-986408 + Nivolumab
|
BMS-986408
Nivolumab
|
0 |
1 |
BMS-986416 + Nivolumab
|
BMS-986416
Nivolumab
|
0 |
1 |
BMS-986449 + Nivolumab
|
BMS-986449
Nivolumab
|
0 |
1 |
BMS-986484 + Nivolumab
|
BMS-986484
Nivolumab
|
0 |
1 |
BND-35 + Nivolumab
|
BND-35
Nivolumab
|
0 |
1 |
BNT111 + Nivolumab
|
BNT111
Nivolumab
|
0 |
0 |
BO-112 + Nivolumab
|
BO-112
Nivolumab
|
0 |
2 |
Brentuximab vedotin + Cyclophosphamide + Doxorubicin + Nivolumab + Prednisone + Rituximab
|
Brentuximab vedotin
Cyclophosphamide
Doxorubicin
Nivolumab
Prednisone
Rituximab
|
0 |
2 |
Brentuximab vedotin + Dacarbazine + Doxorubicin + Nivolumab
|
Brentuximab vedotin
Dacarbazine
Doxorubicin
Nivolumab
|
0 |
1 |
Brentuximab vedotin + Dacarbazine + Doxorubicin + Nivolumab + Rituximab + Vinblastine
|
Brentuximab vedotin
Dacarbazine
Doxorubicin
Nivolumab
Rituximab
Vinblastine
|
0 |
1 |
Brentuximab vedotin + Dacarbazine + Doxorubicin + Nivolumab + Vinblastine
|
Brentuximab vedotin
Dacarbazine
Doxorubicin
Nivolumab
Vinblastine
|
0 |
2 |
Brentuximab vedotin + Nivolumab
|
Brentuximab vedotin
Nivolumab
|
0 |
11 |
Brentuximab vedotin + Nivolumab + Rituximab + Vinblastine
|
Brentuximab vedotin
Nivolumab
Rituximab
Vinblastine
|
0 |
1 |
BT5528 + Nivolumab
|
BT5528
Nivolumab
|
0 |
1 |
BT7480 + Nivolumab
|
BT7480
Nivolumab
|
0 |
1 |
BT8009 + Nivolumab
|
BT8009
Nivolumab
|
0 |
0 |
CA-4948 + Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin
|
CA-4948
Fluorouracil
Leucovorin
Nivolumab
Oxaliplatin
|
0 |
1 |
Cabazitaxel + Carboplatin + Ipilimumab + Nivolumab
|
Cabazitaxel
Carboplatin
Ipilimumab
Nivolumab
|
0 |
1 |
Cabiralizumab + Carboplatin + Nivolumab + Paclitaxel
|
Cabiralizumab
Carboplatin
Nivolumab
Paclitaxel
|
0 |
1 |
Cabiralizumab + Fluorouracil + Irinotecan + Leucovorin + Nivolumab
|
Cabiralizumab
Fluorouracil
Irinotecan
Leucovorin
Nivolumab
|
0 |
1 |
Cabiralizumab + Gemcitabine + Nab-paclitaxel + Nivolumab
|
Cabiralizumab
Gemcitabine
Nab-paclitaxel
Nivolumab
|
0 |
1 |
Cabiralizumab + Gemcitabine + Nivolumab
|
Cabiralizumab
Gemcitabine
Nivolumab
|
0 |
1 |
Cabiralizumab + Nivolumab
|
Cabiralizumab
Nivolumab
|
0 |
8 |
Cabiralizumab + Nivolumab + Sotigalimab
|
Cabiralizumab
Nivolumab
Sotigalimab
|
0 |
1 |
Cabozantinib + CBM588 + Nivolumab
|
CBM588
Cabozantinib
Nivolumab
|
0 |
1 |
Cabozantinib + Ipilimumab + Nivolumab
|
Cabozantinib
Ipilimumab
Nivolumab
|
0 |
16 |
Cabozantinib + Nivolumab
|
Cabozantinib
Nivolumab
|
0 |
28 |
Camu camu + Ipilimumab + Nivolumab
|
Camu camu
Ipilimumab
Nivolumab
|
0 |
1 |
Canerpaturev + Nivolumab
|
Canerpaturev
Nivolumab
|
0 |
1 |
Capecitabine + Cyclophosphamide + Nivolumab + Vinblastine
|
Capecitabine
Cyclophosphamide
Nivolumab
Vinblastine
|
0 |
1 |
Capecitabine + Datopotamab deruxtecan + Nivolumab
|
Capecitabine
Datopotamab deruxtecan
Nivolumab
|
0 |
1 |
Capecitabine + Ipilimumab + Nivolumab
|
Capecitabine
Ipilimumab
Nivolumab
|
0 |
1 |
Capecitabine + Nivolumab
|
Capecitabine
Nivolumab
|
0 |
2 |
Capecitabine + Nivolumab + Oxaliplatin
|
Capecitabine
Nivolumab
Oxaliplatin
|
8 |
4 |
Capecitabine + Nivolumab + Oxaliplatin + Relatlimab
|
Capecitabine
Nivolumab
Oxaliplatin
Relatlimab
|
0 |
1 |
Capecitabine + Nivolumab + Oxaliplatin + RO7496353
|
Capecitabine
Nivolumab
Oxaliplatin
RO7496353
|
0 |
1 |
Capecitabine + Nivolumab + Oxaliplatin + Tegafur-gimeracil-oteracil Potassium
|
Capecitabine
Nivolumab
Oxaliplatin
Tegafur-gimeracil-oteracil Potassium
|
0 |
0 |
Capmatinib + Nivolumab
|
Capmatinib
Nivolumab
|
0 |
1 |
Carboplatin + Certolizumab pegol + Gemcitabine + Nivolumab
|
Carboplatin
Certolizumab pegol
Gemcitabine
Nivolumab
|
0 |
1 |
Carboplatin + Certolizumab pegol + Nivolumab + Pemetrexed Disodium
|
Carboplatin
Certolizumab pegol
Nivolumab
Pemetrexed Disodium
|
0 |
1 |
Carboplatin + Cisplatin + Epacadostat + Fluorouracil + Nivolumab
|
Carboplatin
Cisplatin
Epacadostat
Fluorouracil
Nivolumab
|
0 |
1 |
Carboplatin + Cisplatin + Epacadostat + Gemcitabine + Nivolumab + Paclitaxel + Pemetrexed Disodium
|
Carboplatin
Cisplatin
Epacadostat
Gemcitabine
Nivolumab
Paclitaxel
Pemetrexed Disodium
|
0 |
1 |
Carboplatin + Cisplatin + Fluorouracil + Nivolumab
|
Carboplatin
Cisplatin
Fluorouracil
Nivolumab
|
0 |
1 |
Carboplatin + Cisplatin + Gemcitabine + Nivolumab + Paclitaxel + Pemetrexed Disodium
|
Carboplatin
Cisplatin
Gemcitabine
Nivolumab
Paclitaxel
Pemetrexed Disodium
|
0 |
1 |
Carboplatin + Cisplatin + Nivolumab + Paclitaxel + Pemetrexed Disodium
|
Carboplatin
Cisplatin
Nivolumab
Paclitaxel
Pemetrexed Disodium
|
0 |
1 |
Carboplatin + Docetaxel + Nivolumab
|
Carboplatin
Docetaxel
Nivolumab
|
0 |
3 |
Carboplatin + Etoposide + Ifosfamide + Nivolumab
|
Carboplatin
Etoposide
Ifosfamide
Nivolumab
|
0 |
1 |
Carboplatin + Etoposide + Nivolumab
|
Carboplatin
Etoposide
Nivolumab
|
0 |
3 |
Carboplatin + Gemcitabine + Nivolumab
|
Carboplatin
Gemcitabine
Nivolumab
|
0 |
8 |
Carboplatin + GL-ONC1 + Nab-paclitaxel + Nivolumab
|
Carboplatin
GL-ONC1
Nab-paclitaxel
Nivolumab
|
0 |
1 |
Carboplatin + GL-ONC1 + Nivolumab + Paclitaxel
|
Carboplatin
GL-ONC1
Nivolumab
Paclitaxel
|
0 |
1 |
Carboplatin + GL-ONC1 + Nivolumab + Pemetrexed Disodium
|
Carboplatin
GL-ONC1
Nivolumab
Pemetrexed Disodium
|
0 |
1 |
Carboplatin + Ipilimumab + Nivolumab + Paclitaxel
|
Carboplatin
Ipilimumab
Nivolumab
Paclitaxel
|
0 |
4 |
Carboplatin + Ipilimumab + Nivolumab + Pemetrexed Disodium
|
Carboplatin
Ipilimumab
Nivolumab
Pemetrexed Disodium
|
0 |
3 |
Carboplatin + Nab-paclitaxel + Nivolumab
|
Carboplatin
Nab-paclitaxel
Nivolumab
|
0 |
1 |
Carboplatin + Nab-paclitaxel + Nivolumab + Pemetrexed Disodium
|
Carboplatin
Nab-paclitaxel
Nivolumab
Pemetrexed Disodium
|
0 |
1 |
Carboplatin + Nab-paclitaxel + Nivolumab + Pemetrexed Disodium + Relatlimab
|
Carboplatin
Nab-paclitaxel
Nivolumab
Pemetrexed Disodium
Relatlimab
|
0 |
1 |
Carboplatin + Nivolumab
|
Carboplatin
Nivolumab
|
0 |
2 |
Carboplatin + Nivolumab + Paclitaxel
|
Carboplatin
Nivolumab
Paclitaxel
|
0 |
19 |
Carboplatin + Nivolumab + Paclitaxel + Pemetrexed Disodium
|
Carboplatin
Nivolumab
Paclitaxel
Pemetrexed Disodium
|
0 |
1 |
Carboplatin + Nivolumab + Paclitaxel + Pemetrexed Disodium + Relatlimab
|
Carboplatin
Nivolumab
Paclitaxel
Pemetrexed Disodium
Relatlimab
|
0 |
1 |
Carboplatin + Nivolumab + Paclitaxel + Pemetrexed Disodium + Veliparib
|
Carboplatin
Nivolumab
Paclitaxel
Pemetrexed Disodium
Veliparib
|
0 |
1 |
Carboplatin + Nivolumab + Pemetrexed Disodium
|
Carboplatin
Nivolumab
Pemetrexed Disodium
|
0 |
11 |
Carboplatin + Nivolumab + Pemetrexed Disodium + Relatlimab
|
Carboplatin
Nivolumab
Pemetrexed Disodium
Relatlimab
|
0 |
1 |
Carfilzomib + Dexamethasone + Nivolumab
|
Carfilzomib
Dexamethasone
Nivolumab
|
0 |
1 |
Carfilzomib + Dexamethasone + Nivolumab + Pelareorep
|
Carfilzomib
Dexamethasone
Nivolumab
Pelareorep
|
0 |
1 |
Carotuximab + Nivolumab
|
Carotuximab
Nivolumab
|
0 |
1 |
CBL0137 + Ipilimumab + Nivolumab
|
CBL0137
Ipilimumab
Nivolumab
|
0 |
1 |
CBM588 + Ipilimumab + Nivolumab
|
CBM588
Ipilimumab
Nivolumab
|
0 |
2 |
CBP501 + Cisplatin + Nivolumab
|
CBP501
Cisplatin
Nivolumab
|
0 |
2 |
CC-122 + Nivolumab
|
CC-122
Nivolumab
|
0 |
2 |
CC-90001 + Nivolumab
|
CC-90001
Nivolumab
|
0 |
1 |
CC-90011 + Nivolumab
|
CC-90011
Nivolumab
|
0 |
1 |
CC-99282 + Nivolumab + Rituximab
|
CC-99282
Nivolumab
Rituximab
|
0 |
1 |
CD24Fc + Ipilimumab + Nivolumab
|
CD24Fc
Ipilimumab
Nivolumab
|
0 |
1 |
CDX-301 + INO-5151 + Nivolumab
|
CDX-301
INO-5151
Nivolumab
|
0 |
1 |
CDX-301 + Nivolumab + Poly ICLC
|
CDX-301
Nivolumab
Poly ICLC
|
0 |
2 |
Celecoxib + Ipilimumab + Nivolumab
|
Celecoxib
Ipilimumab
Nivolumab
|
0 |
1 |
CEP-11981 + Nivolumab
|
CEP-11981
Nivolumab
|
0 |
2 |
Ceritinib + Nivolumab
|
Ceritinib
Nivolumab
|
0 |
1 |
Certolizumab pegol + Cisplatin + Gemcitabine + Nivolumab
|
Certolizumab pegol
Cisplatin
Gemcitabine
Nivolumab
|
0 |
1 |
Certolizumab pegol + Cisplatin + Nivolumab + Pemetrexed Disodium
|
Certolizumab pegol
Cisplatin
Nivolumab
Pemetrexed Disodium
|
0 |
1 |
Cetuximab + Encorafenib + Nivolumab
|
Cetuximab
Encorafenib
Nivolumab
|
0 |
2 |
Cetuximab + Nivolumab
|
Cetuximab
Nivolumab
|
0 |
4 |
CG0070 + Nivolumab
|
CG0070
Nivolumab
|
0 |
1 |
Chidamide + Nivolumab
|
Chidamide
Nivolumab
|
0 |
2 |
CIMAvax-EGF + Nivolumab
|
CIMAvax-EGF
Nivolumab
|
0 |
1 |
Cisplatin + Docetaxel + Nivolumab
|
Cisplatin
Docetaxel
Nivolumab
|
0 |
4 |
Cisplatin + Doxorubicin + Methotrexate + Nivolumab + Vinblastine
|
Cisplatin
Doxorubicin
Methotrexate
Nivolumab
Vinblastine
|
0 |
1 |
Cisplatin + Etoposide + Nivolumab
|
Cisplatin
Etoposide
Nivolumab
|
0 |
2 |
Cisplatin + Fluorouracil + Nivolumab
|
Cisplatin
Fluorouracil
Nivolumab
|
0 |
1 |
Cisplatin + Gemcitabine + Linrodostat + Nivolumab
|
Cisplatin
Gemcitabine
Linrodostat
Nivolumab
|
0 |
1 |
Cisplatin + Gemcitabine + Nab-paclitaxel + Nivolumab + Paricalcitol
|
Cisplatin
Gemcitabine
Nab-paclitaxel
Nivolumab
Paricalcitol
|
0 |
1 |
Cisplatin + Gemcitabine + Nivolumab
|
Cisplatin
Gemcitabine
Nivolumab
|
0 |
13 |
Cisplatin + GL-ONC1 + Nab-paclitaxel + Nivolumab
|
Cisplatin
GL-ONC1
Nab-paclitaxel
Nivolumab
|
0 |
1 |
Cisplatin + GL-ONC1 + Nivolumab + Paclitaxel
|
Cisplatin
GL-ONC1
Nivolumab
Paclitaxel
|
0 |
1 |
Cisplatin + GL-ONC1 + Nivolumab + Pemetrexed Disodium
|
Cisplatin
GL-ONC1
Nivolumab
Pemetrexed Disodium
|
0 |
1 |
Cisplatin + Ipilimumab + Nivolumab + Pemetrexed Disodium
|
Cisplatin
Ipilimumab
Nivolumab
Pemetrexed Disodium
|
0 |
2 |
Cisplatin + Nab-paclitaxel + Nivolumab
|
Cisplatin
Nab-paclitaxel
Nivolumab
|
0 |
1 |
Cisplatin + Nab-paclitaxel + Nivolumab + Pemetrexed Disodium
|
Cisplatin
Nab-paclitaxel
Nivolumab
Pemetrexed Disodium
|
0 |
1 |
Cisplatin + Nab-paclitaxel + Nivolumab + Pemetrexed Disodium + Relatlimab
|
Cisplatin
Nab-paclitaxel
Nivolumab
Pemetrexed Disodium
Relatlimab
|
0 |
1 |
Cisplatin + Nivolumab
|
Cisplatin
Nivolumab
|
0 |
10 |
Cisplatin + Nivolumab + Paclitaxel
|
Cisplatin
Nivolumab
Paclitaxel
|
0 |
2 |
Cisplatin + Nivolumab + Paclitaxel + Pemetrexed Disodium
|
Cisplatin
Nivolumab
Paclitaxel
Pemetrexed Disodium
|
0 |
1 |
Cisplatin + Nivolumab + Paclitaxel + Pemetrexed Disodium + Relatlimab
|
Cisplatin
Nivolumab
Paclitaxel
Pemetrexed Disodium
Relatlimab
|
0 |
1 |
Cisplatin + Nivolumab + Pemetrexed Disodium
|
Cisplatin
Nivolumab
Pemetrexed Disodium
|
0 |
9 |
Cisplatin + Nivolumab + Pemetrexed Disodium + Relatlimab
|
Cisplatin
Nivolumab
Pemetrexed Disodium
Relatlimab
|
0 |
1 |
Cisplatin + Nivolumab + Romidepsin
|
Cisplatin
Nivolumab
Romidepsin
|
0 |
1 |
Cisplatin + Nivolumab + Temozolomide
|
Cisplatin
Nivolumab
Temozolomide
|
0 |
1 |
Citarinostat + Ipilimumab + Nivolumab
|
Citarinostat
Ipilimumab
Nivolumab
|
0 |
2 |
CM-24 + Nab-paclitaxel + Nivolumab
|
CM-24
Nab-paclitaxel
Nivolumab
|
0 |
1 |
CM-24 + Nivolumab
|
CM-24
Nivolumab
|
0 |
1 |
Cobimetinib + Ipilimumab + Nivolumab
|
Cobimetinib
Ipilimumab
Nivolumab
|
0 |
1 |
Cobolimab + Nivolumab
|
Cobolimab
Nivolumab
|
0 |
1 |
COM701 + Nivolumab
|
COM701
Nivolumab
|
0 |
1 |
Copanlisib + Ipilimumab + Nivolumab
|
Copanlisib
Ipilimumab
Nivolumab
|
0 |
1 |
Copanlisib + Nivolumab
|
Copanlisib
Nivolumab
|
3 |
6 |
Copanlisib + Nivolumab + Rituximab
|
Copanlisib
Nivolumab
Rituximab
|
0 |
1 |
CP-506 + Nivolumab
|
CP-506
Nivolumab
|
0 |
1 |
CPI-444 + Ipilimumab + Nivolumab
|
CPI-444
Ipilimumab
Nivolumab
|
0 |
1 |
Crizanlizumab + Nivolumab
|
Crizanlizumab
Nivolumab
|
0 |
1 |
Crizotinib + Nivolumab
|
Crizotinib
Nivolumab
|
0 |
1 |
CRS-207 + Cyclophosphamide + GVAX pancreatic cancer vaccine + Ipilimumab + Nivolumab
|
CRS-207
Cyclophosphamide
GVAX pancreatic cancer vaccine
Ipilimumab
Nivolumab
|
0 |
1 |
CRS-207 + Ipilimumab + Nivolumab
|
CRS-207
Ipilimumab
Nivolumab
|
0 |
1 |
CTL-002 + Nivolumab
|
CTL-002
Nivolumab
|
0 |
1 |
CV301 + Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin
|
CV301
Fluorouracil
Leucovorin
Nivolumab
Oxaliplatin
|
0 |
1 |
CV301 + Nivolumab
|
CV301
Nivolumab
|
0 |
1 |
Cyclophosphamide + Dexamethasone + Ixazomib + Nivolumab
|
Cyclophosphamide
Dexamethasone
Ixazomib
Nivolumab
|
0 |
1 |
Cyclophosphamide + Doxorubicin + Etoposide + Filgrastim + Nivolumab + Prednisone + Rituximab + Vincristine Sulfate
|
Cyclophosphamide
Doxorubicin
Etoposide
Filgrastim
Nivolumab
Prednisone
Rituximab
Vincristine Sulfate
|
0 |
1 |
Cyclophosphamide + Doxorubicin + Etoposide + Nivolumab + Prednisone + Rituximab + Vincristine Sulfate
|
Cyclophosphamide
Doxorubicin
Etoposide
Nivolumab
Prednisone
Rituximab
Vincristine Sulfate
|
0 |
2 |
Cyclophosphamide + Doxorubicin + Etoposide + Nivolumab + Prednisone + Vincristine Sulfate
|
Cyclophosphamide
Doxorubicin
Etoposide
Nivolumab
Prednisone
Vincristine Sulfate
|
0 |
1 |
Cyclophosphamide + Doxorubicin + Nivolumab + Prednisone + Rituximab + Vincristine Sulfate
|
Cyclophosphamide
Doxorubicin
Nivolumab
Prednisone
Rituximab
Vincristine Sulfate
|
0 |
2 |
Cyclophosphamide + Fludarabine + HER2 CAR-T cells + Nivolumab
|
Cyclophosphamide
Fludarabine
HER2 CAR-T cells
Nivolumab
|
0 |
0 |
Cyclophosphamide + Fludarabine + HPVST cells + Nivolumab
|
Cyclophosphamide
Fludarabine
HPVST cells
Nivolumab
|
0 |
1 |
Cyclophosphamide + Fludarabine + Nivolumab
|
Cyclophosphamide
Fludarabine
Nivolumab
|
0 |
0 |
Cyclophosphamide + GVAX pancreatic cancer vaccine + Nivolumab
|
Cyclophosphamide
GVAX pancreatic cancer vaccine
Nivolumab
|
0 |
1 |
Cyclophosphamide + Ipilimumab + Nivolumab
|
Cyclophosphamide
Ipilimumab
Nivolumab
|
0 |
1 |
Cyclophosphamide + IRX-2 + Nivolumab
|
Cyclophosphamide
IRX-2
Nivolumab
|
0 |
3 |
Cyclophosphamide + Nivolumab
|
Cyclophosphamide
Nivolumab
|
0 |
1 |
Cyclophosphamide + Nivolumab + PG545
|
Cyclophosphamide
Nivolumab
PG545
|
0 |
1 |
Cyclophosphamide + Nivolumab + Vinblastine
|
Cyclophosphamide
Nivolumab
Vinblastine
|
0 |
1 |
Cytarabine + Idarubicin + Nivolumab
|
Cytarabine
Idarubicin
Nivolumab
|
0 |
1 |
Dabrafenib + Ipilimumab + Nivolumab
|
Dabrafenib
Ipilimumab
Nivolumab
|
0 |
1 |
Dabrafenib + Ipilimumab + Nivolumab + Trametinib
|
Dabrafenib
Ipilimumab
Nivolumab
Trametinib
|
0 |
1 |
Dabrafenib + Nivolumab + Trametinib
|
Dabrafenib
Nivolumab
Trametinib
|
2 |
2 |
Dacarbazine + Doxorubicin + Nivolumab + Vinblastine
|
Dacarbazine
Doxorubicin
Nivolumab
Vinblastine
|
0 |
2 |
Daratumumab + Dexamethasone + Nivolumab + Pomalidomide
|
Daratumumab
Dexamethasone
Nivolumab
Pomalidomide
|
0 |
1 |
Daratumumab + Nivolumab
|
Daratumumab
Nivolumab
|
0 |
2 |
Daratumumab + Nivolumab + QS21 + TG01
|
Daratumumab
Nivolumab
QS21
TG01
|
0 |
1 |
Daratumumab + Nivolumab + TG01
|
Daratumumab
Nivolumab
TG01
|
0 |
0 |
Dasatinib + Nivolumab
|
Dasatinib
Nivolumab
|
0 |
3 |
Datopotamab deruxtecan + Fluorouracil + Nivolumab
|
Datopotamab deruxtecan
Fluorouracil
Nivolumab
|
0 |
1 |
DC myeloma fusion vaccine + Nivolumab
|
DC myeloma fusion vaccine
Nivolumab
|
0 |
1 |
DC tumor cell lysate vaccine + Ipilimumab + Nivolumab + Poly ICLC
|
DC tumor cell lysate vaccine
Ipilimumab
Nivolumab
Poly ICLC
|
0 |
1 |
DC tumor cell lysate vaccine + Nivolumab + Poly ICLC
|
DC tumor cell lysate vaccine
Nivolumab
Poly ICLC
|
0 |
1 |
DCVax-L + Nivolumab
|
DCVax-L
Nivolumab
|
0 |
1 |
Decitabine + Nivolumab + Poly ICLC + Rasdegafusp alfa
|
Decitabine
Nivolumab
Poly ICLC
Rasdegafusp alfa
|
0 |
1 |
Decitabine + Nivolumab + Tetrahydrouridine
|
Decitabine
Nivolumab
Tetrahydrouridine
|
0 |
1 |
Decitabine + Nivolumab + Venetoclax
|
Decitabine
Nivolumab
Venetoclax
|
0 |
1 |
Decitabine and Cedazuridine + Nivolumab
|
Decitabine and Cedazuridine
Nivolumab
|
0 |
3 |
Defactinib + Nivolumab + RO5126766
|
Defactinib
Nivolumab
RO5126766
|
0 |
1 |
Degarelix + Nivolumab
|
Degarelix
Nivolumab
|
0 |
1 |
Degarelix + Nivolumab + pTVG-AR
|
Degarelix
Nivolumab
pTVG-AR
|
0 |
1 |
Denosumab + Ipilimumab + Nivolumab
|
Denosumab
Ipilimumab
Nivolumab
|
0 |
1 |
Denosumab + Nivolumab
|
Denosumab
Nivolumab
|
0 |
1 |
Denosumab + Nivolumab + RXC004
|
Denosumab
Nivolumab
RXC004
|
0 |
1 |
Dexamethasone + Elotuzumab + Nivolumab + Pomalidomide
|
Dexamethasone
Elotuzumab
Nivolumab
Pomalidomide
|
0 |
1 |
Dexamethasone + Lenalidomide + Nivolumab
|
Dexamethasone
Lenalidomide
Nivolumab
|
0 |
1 |
DF6002 + Nivolumab
|
DF6002
Nivolumab
|
0 |
1 |
DF9001 + Nivolumab
|
DF9001
Nivolumab
|
0 |
1 |
Dinutuximab beta + Nivolumab
|
Dinutuximab beta
Nivolumab
|
0 |
1 |
DK210 + Nivolumab
|
DK210
Nivolumab
|
0 |
1 |
DKN-01 + Nivolumab
|
DKN-01
Nivolumab
|
0 |
1 |
DNAJB1-PRKACA peptide vaccine + Ipilimumab + MUC1 peptide-Poly-ICLC vaccine + Nivolumab
|
DNAJB1-PRKACA peptide vaccine
Ipilimumab
MUC1 peptide-Poly-ICLC vaccine
Nivolumab
|
0 |
0 |
DNAJB1-PRKACA peptide vaccine + Ipilimumab + Nivolumab + Poly ICLC
|
DNAJB1-PRKACA peptide vaccine
Ipilimumab
Nivolumab
Poly ICLC
|
0 |
1 |
Docetaxel + Doxorubicin + Gemcitabine + Nivolumab
|
Docetaxel
Doxorubicin
Gemcitabine
Nivolumab
|
0 |
1 |
Docetaxel + Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin
|
Docetaxel
Fluorouracil
Leucovorin
Nivolumab
Oxaliplatin
|
0 |
2 |
Docetaxel + Nivolumab
|
Docetaxel
Nivolumab
|
0 |
4 |
Docetaxel + Nivolumab + Pertuzumab + Trastuzumab
|
Docetaxel
Nivolumab
Pertuzumab
Trastuzumab
|
0 |
1 |
Docetaxel + Nivolumab + Prednisone
|
Docetaxel
Nivolumab
Prednisone
|
0 |
1 |
Docetaxel + Nivolumab + Ramucirumab
|
Docetaxel
Nivolumab
Ramucirumab
|
0 |
1 |
Doxorubicin + Nivolumab
|
Doxorubicin
Nivolumab
|
0 |
1 |
DS-8273a + Nivolumab
|
DS-8273a
Nivolumab
|
0 |
2 |
DSP-7888 + Nivolumab
|
DSP-7888
Nivolumab
|
0 |
1 |
Duvelisib + Nivolumab
|
Duvelisib
Nivolumab
|
0 |
3 |
DV281 + Nivolumab
|
DV281
Nivolumab
|
0 |
0 |
EB-VST cells + Nivolumab
|
EB-VST cells
Nivolumab
|
0 |
1 |
Eganelisib + Nivolumab
|
Eganelisib
Nivolumab
|
0 |
1 |
Elotuzumab + Nivolumab
|
Elotuzumab
Nivolumab
|
0 |
1 |
Encorafenib + Ipilimumab + Nivolumab
|
Encorafenib
Ipilimumab
Nivolumab
|
0 |
1 |
Entinostat + H1299 cell lysate vaccine + Montanide ISA 51 + Nivolumab
|
Entinostat
H1299 cell lysate vaccine
Montanide ISA 51
Nivolumab
|
0 |
1 |
Entinostat + Ipilimumab + Nivolumab
|
Entinostat
Ipilimumab
Nivolumab
|
0 |
2 |
Entinostat + Nivolumab
|
Entinostat
Nivolumab
|
0 |
2 |
Enzalutamide + Nivolumab
|
Enzalutamide
Nivolumab
|
0 |
1 |
EO2040 + Nivolumab
|
EO2040
Nivolumab
|
0 |
1 |
EO2401 + Nivolumab
|
EO2401
Nivolumab
|
0 |
1 |
EO4010 + Nivolumab
|
EO4010
Nivolumab
|
0 |
1 |
Epacadostat + Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin
|
Epacadostat
Fluorouracil
Leucovorin
Nivolumab
Oxaliplatin
|
0 |
1 |
Epacadostat + Gemcitabine + Nab-paclitaxel + Nivolumab
|
Epacadostat
Gemcitabine
Nab-paclitaxel
Nivolumab
|
0 |
1 |
Epacadostat + Ipilimumab + Nivolumab
|
Epacadostat
Ipilimumab
Nivolumab
|
0 |
1 |
Epacadostat + Lirilumab + Nivolumab
|
Epacadostat
Lirilumab
Nivolumab
|
0 |
1 |
Epacadostat + Nivolumab
|
Epacadostat
Nivolumab
|
0 |
2 |
Eribulin + Nivolumab
|
Eribulin
Nivolumab
|
0 |
0 |
Erlotinib + Nivolumab
|
Erlotinib
Nivolumab
|
0 |
1 |
Etigilimab + Nivolumab
|
Etigilimab
Nivolumab
|
0 |
2 |
Evolocumab + Ipilimumab + Nivolumab
|
Evolocumab
Ipilimumab
Nivolumab
|
0 |
1 |
Evolocumab + Nivolumab
|
Evolocumab
Nivolumab
|
0 |
1 |
EVX-02 + Nivolumab
|
EVX-02
Nivolumab
|
0 |
1 |
EXL01 + Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin
|
EXL01
Fluorouracil
Leucovorin
Nivolumab
Oxaliplatin
|
0 |
1 |
FANG vaccine + Nivolumab
|
FANG vaccine
Nivolumab
|
0 |
1 |
Fecal microbiota + Nivolumab
|
Fecal microbiota
Nivolumab
|
0 |
1 |
FL-101 + Nivolumab
|
FL-101
Nivolumab
|
0 |
1 |
Fluorouracil + Ipilimumab + Leucovorin + Nivolumab + Oxaliplatin
|
Fluorouracil
Ipilimumab
Leucovorin
Nivolumab
Oxaliplatin
|
0 |
1 |
Fluorouracil + Ipilimumab + Nivolumab
|
Fluorouracil
Ipilimumab
Nivolumab
|
0 |
1 |
Fluorouracil + Irinotecan + Leucovorin + Losartan + Nivolumab + Oxaliplatin
|
Fluorouracil
Irinotecan
Leucovorin
Losartan
Nivolumab
Oxaliplatin
|
0 |
1 |
Fluorouracil + Irinotecan + Leucovorin + Nivolumab
|
Fluorouracil
Irinotecan
Leucovorin
Nivolumab
|
0 |
1 |
Fluorouracil + Irinotecan + Leucovorin + Nivolumab + Oxaliplatin
|
Fluorouracil
Irinotecan
Leucovorin
Nivolumab
Oxaliplatin
|
0 |
3 |
Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin
|
Fluorouracil
Leucovorin
Nivolumab
Oxaliplatin
|
0 |
10 |
Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin + Regorafenib
|
Fluorouracil
Leucovorin
Nivolumab
Oxaliplatin
Regorafenib
|
0 |
1 |
Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin + Relatlimab
|
Fluorouracil
Leucovorin
Nivolumab
Oxaliplatin
Relatlimab
|
0 |
1 |
Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin + SOT102
|
Fluorouracil
Leucovorin
Nivolumab
Oxaliplatin
SOT102
|
0 |
1 |
Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin + Zolbetuximab
|
Fluorouracil
Leucovorin
Nivolumab
Oxaliplatin
Zolbetuximab
|
0 |
1 |
Fluorouracil + Nivolumab + Novaferon
|
Fluorouracil
Nivolumab
Novaferon
|
0 |
1 |
Fluorouracil + Nivolumab + Oxaliplatin
|
Fluorouracil
Nivolumab
Oxaliplatin
|
7 |
0 |
FT500 + Nivolumab
|
FT500
Nivolumab
|
0 |
1 |
FT538 + Nivolumab
|
FT538
Nivolumab
|
0 |
1 |
Galinpepimut-S + Nivolumab + Sargramostim
|
Galinpepimut-S
Nivolumab
Sargramostim
|
0 |
1 |
Gavocabtagene autoleucel + Ipilimumab + Nivolumab
|
Gavocabtagene autoleucel
Ipilimumab
Nivolumab
|
0 |
1 |
Gavocabtagene autoleucel + Nivolumab
|
Gavocabtagene autoleucel
Nivolumab
|
0 |
1 |
Gemcitabine + Ipilimumab + Nab-paclitaxel + Nivolumab
|
Gemcitabine
Ipilimumab
Nab-paclitaxel
Nivolumab
|
0 |
1 |
Gemcitabine + Ipilimumab + Nivolumab
|
Gemcitabine
Ipilimumab
Nivolumab
|
0 |
0 |
Gemcitabine + Nab-paclitaxel + Nivolumab
|
Gemcitabine
Nab-paclitaxel
Nivolumab
|
0 |
2 |
Gemcitabine + Nab-paclitaxel + Nivolumab + Paricalcitol
|
Gemcitabine
Nab-paclitaxel
Nivolumab
Paricalcitol
|
0 |
1 |
Gemcitabine + Nab-paclitaxel + Nivolumab + Sotigalimab
|
Gemcitabine
Nab-paclitaxel
Nivolumab
Sotigalimab
|
0 |
1 |
Gemcitabine + Nivolumab
|
Gemcitabine
Nivolumab
|
0 |
3 |
Gemcitabine + Nivolumab + Oxaliplatin
|
Gemcitabine
Nivolumab
Oxaliplatin
|
0 |
1 |
Gemcitabine + Nivolumab + Oxaliplatin + Rituximab
|
Gemcitabine
Nivolumab
Oxaliplatin
Rituximab
|
0 |
1 |
GEN-009 + Nivolumab
|
GEN-009
Nivolumab
|
0 |
1 |
Glesatinib + Nivolumab
|
Glesatinib
Nivolumab
|
0 |
1 |
GNOS-PV01 + INO-9012 + Ipilimumab + Nivolumab
|
GNOS-PV01
INO-9012
Ipilimumab
Nivolumab
|
0 |
0 |
GNOS-PV01 + INO-9012 + Nivolumab
|
GNOS-PV01
INO-9012
Nivolumab
|
0 |
0 |
GRT-C901 + GRT-R902 + Ipilimumab + Nivolumab
|
GRT-C901
GRT-R902
Ipilimumab
Nivolumab
|
0 |
1 |
GRT-C903 + GRT-R904 + Ipilimumab + Nivolumab
|
GRT-C903
GRT-R904
Ipilimumab
Nivolumab
|
0 |
1 |
Guadecitabine + Ipilimumab + Nivolumab
|
Guadecitabine
Ipilimumab
Nivolumab
|
0 |
1 |
Guadecitabine + Nivolumab
|
Guadecitabine
Nivolumab
|
0 |
1 |
GVAX + Ipilimumab + Nivolumab
|
GVAX
Ipilimumab
Nivolumab
|
0 |
1 |
H3.3K27M peptide vaccine + Montanide ISA 51 + Nivolumab + Poly ICLC + Tetanus Toxoid peptide
|
H3.3K27M peptide vaccine
Montanide ISA 51
Nivolumab
Poly ICLC
Tetanus Toxoid peptide
|
0 |
1 |
HB-201 + HB-202 + Nivolumab
|
HB-201
HB-202
Nivolumab
|
0 |
1 |
HB-201 + Nivolumab
|
HB-201
Nivolumab
|
0 |
1 |
HER2 CAR-T cells + Nivolumab
|
HER2 CAR-T cells
Nivolumab
|
0 |
1 |
HS-110 + Nivolumab
|
HS-110
Nivolumab
|
0 |
0 |
hu14.18-IL2 + Ipilimumab + Nivolumab
|
Ipilimumab
Nivolumab
hu14.18-IL2
|
0 |
1 |
hu14.18-IL2 + Nivolumab
|
Nivolumab
hu14.18-IL2
|
0 |
1 |
Hydroxychloroquine + Ipilimumab + Nivolumab
|
Hydroxychloroquine
Ipilimumab
Nivolumab
|
0 |
1 |
Hydroxychloroquine + Nivolumab
|
Hydroxychloroquine
Nivolumab
|
0 |
1 |
Ibrutinib + Ipilimumab + Nivolumab
|
Ibrutinib
Ipilimumab
Nivolumab
|
0 |
1 |
Ibrutinib + Nivolumab
|
Ibrutinib
Nivolumab
|
0 |
8 |
IMC-F106C + Nivolumab
|
IMC-F106C
Nivolumab
|
0 |
1 |
IMO-2125 + Ipilimumab + Nivolumab
|
IMO-2125
Ipilimumab
Nivolumab
|
0 |
2 |
IMO-2125 + Nivolumab
|
IMO-2125
Nivolumab
|
0 |
1 |
IMSA101 + Nivolumab
|
IMSA101
Nivolumab
|
0 |
3 |
INCAGN01876 + Ipilimumab + Nivolumab
|
INCAGN01876
Ipilimumab
Nivolumab
|
0 |
1 |
INCAGN01876 + Nivolumab
|
INCAGN01876
Nivolumab
|
0 |
1 |
INCAGN01949 + Ipilimumab + Nivolumab
|
INCAGN01949
Ipilimumab
Nivolumab
|
0 |
1 |
INCAGN01949 + Nivolumab
|
INCAGN01949
Nivolumab
|
0 |
1 |
INCB001158 + Nivolumab
|
INCB001158
Nivolumab
|
0 |
1 |
INCB081776 + Nivolumab
|
INCB081776
Nivolumab
|
0 |
1 |
Indoximod + Nivolumab
|
Indoximod
Nivolumab
|
0 |
1 |
INI-4001 + Nivolumab
|
INI-4001
Nivolumab
|
0 |
1 |
IO102-IO103 + Nivolumab
|
IO102-IO103
Nivolumab
|
0 |
1 |
Ipilimumab + Ivosidenib + Nivolumab
|
Ipilimumab
Ivosidenib
Nivolumab
|
0 |
1 |
Ipilimumab + Linrodostat + Nivolumab
|
Ipilimumab
Linrodostat
Nivolumab
|
0 |
1 |
Ipilimumab + Lurbinectedin + Nivolumab
|
Ipilimumab
Lurbinectedin
Nivolumab
|
0 |
1 |
Ipilimumab + lutetium Lu 177 vipivotide tetraxetan + Nivolumab
|
Ipilimumab
Nivolumab
lutetium Lu 177 vipivotide tetraxetan
|
0 |
1 |
Ipilimumab + MaaT013 + Nivolumab
|
Ipilimumab
MaaT013
Nivolumab
|
0 |
1 |
Ipilimumab + Mebendazole + Nivolumab + Sorafenib
|
Ipilimumab
Mebendazole
Nivolumab
Sorafenib
|
0 |
0 |
Ipilimumab + Melphalan + Nivolumab
|
Ipilimumab
Melphalan
Nivolumab
|
0 |
2 |
Ipilimumab + Mocetinostat + Nivolumab
|
Ipilimumab
Mocetinostat
Nivolumab
|
0 |
1 |
Ipilimumab + Nab-paclitaxel + Nivolumab
|
Ipilimumab
Nab-paclitaxel
Nivolumab
|
0 |
1 |
Ipilimumab + NBTXR3 + Nivolumab
|
Ipilimumab
NBTXR3
Nivolumab
|
0 |
1 |
Ipilimumab + NEO-PV-01 + Nivolumab + Poly ICLC
|
Ipilimumab
NEO-PV-01
Nivolumab
Poly ICLC
|
0 |
1 |
Ipilimumab + NeoVax + Nivolumab
|
Ipilimumab
NeoVax
Nivolumab
|
0 |
2 |
Ipilimumab + Nintedanib + Nivolumab
|
Ipilimumab
Nintedanib
Nivolumab
|
0 |
1 |
Ipilimumab + Nivolumab
|
Ipilimumab
Nivolumab
|
35 |
243 |
Ipilimumab + Nivolumab + Oxaliplatin
|
Ipilimumab
Nivolumab
Oxaliplatin
|
0 |
1 |
Ipilimumab + Nivolumab + Paclitaxel
|
Ipilimumab
Nivolumab
Paclitaxel
|
0 |
1 |
Ipilimumab + Nivolumab + Panitumumab
|
Ipilimumab
Nivolumab
Panitumumab
|
0 |
1 |
Ipilimumab + Nivolumab + Pepinemab
|
Ipilimumab
Nivolumab
Pepinemab
|
0 |
1 |
Ipilimumab + Nivolumab + Plinabulin
|
Ipilimumab
Nivolumab
Plinabulin
|
0 |
1 |
Ipilimumab + Nivolumab + Poly ICLC
|
Ipilimumab
Nivolumab
Poly ICLC
|
0 |
1 |
Ipilimumab + Nivolumab + Poly ICLC + Pooled Mutant KRAS-Targeted Long Peptide Vaccine
|
Ipilimumab
Nivolumab
Poly ICLC
Pooled Mutant KRAS-Targeted Long Peptide Vaccine
|
0 |
2 |
Ipilimumab + Nivolumab + Pooled Mutant KRAS-Targeted Long Peptide Vaccine
|
Ipilimumab
Nivolumab
Pooled Mutant KRAS-Targeted Long Peptide Vaccine
|
0 |
0 |
Ipilimumab + Nivolumab + Prednisone + Sirolimus
|
Ipilimumab
Nivolumab
Prednisone
Sirolimus
|
0 |
1 |
Ipilimumab + Nivolumab + Prednisone + Tacrolimus
|
Ipilimumab
Nivolumab
Prednisone
Tacrolimus
|
0 |
1 |
Ipilimumab + Nivolumab + PROSTVAC-F-TRICOM + PROSTVAC-V-TRICOM
|
Ipilimumab
Nivolumab
PROSTVAC-F-TRICOM
PROSTVAC-V-TRICOM
|
0 |
2 |
Ipilimumab + Nivolumab + PROSTVAC-V-TRICOM
|
Ipilimumab
Nivolumab
PROSTVAC-V-TRICOM
|
0 |
0 |
Ipilimumab + Nivolumab + Regorafenib
|
Ipilimumab
Nivolumab
Regorafenib
|
0 |
1 |
Ipilimumab + Nivolumab + Relatlimab
|
Ipilimumab
Nivolumab
Relatlimab
|
0 |
2 |
Ipilimumab + Nivolumab + rhIL-15
|
Ipilimumab
Nivolumab
rhIL-15
|
0 |
1 |
Ipilimumab + Nivolumab + rHuPH20
|
Ipilimumab
Nivolumab
rHuPH20
|
0 |
1 |
Ipilimumab + Nivolumab + Rituximab
|
Ipilimumab
Nivolumab
Rituximab
|
0 |
1 |
Ipilimumab + Nivolumab + Rovalpituzumab Tesirine
|
Ipilimumab
Nivolumab
Rovalpituzumab Tesirine
|
0 |
1 |
Ipilimumab + Nivolumab + Sacituzumab govitecan-hziy
|
Ipilimumab
Nivolumab
Sacituzumab govitecan-hziy
|
0 |
1 |
Ipilimumab + Nivolumab + Sargramostim + UV1 Telomerase peptide vaccine
|
Ipilimumab
Nivolumab
Sargramostim
UV1 Telomerase peptide vaccine
|
0 |
1 |
Ipilimumab + Nivolumab + SCIB1
|
Ipilimumab
Nivolumab
SCIB1
|
0 |
1 |
Ipilimumab + Nivolumab + SD-101
|
Ipilimumab
Nivolumab
SD-101
|
0 |
2 |
Ipilimumab + Nivolumab + Sitravatinib
|
Ipilimumab
Nivolumab
Sitravatinib
|
0 |
1 |
Ipilimumab + Nivolumab + Sotigalimab
|
Ipilimumab
Nivolumab
Sotigalimab
|
0 |
1 |
Ipilimumab + Nivolumab + SQZ-AAC-HPV
|
Ipilimumab
Nivolumab
SQZ-AAC-HPV
|
0 |
1 |
Ipilimumab + Nivolumab + Talimogene laherparepvec
|
Ipilimumab
Nivolumab
Talimogene laherparepvec
|
0 |
1 |
Ipilimumab + Nivolumab + Tazemetostat
|
Ipilimumab
Nivolumab
Tazemetostat
|
0 |
1 |
Ipilimumab + Nivolumab + Temozolomide
|
Ipilimumab
Nivolumab
Temozolomide
|
0 |
1 |
Ipilimumab + Nivolumab + Temsirolimus
|
Ipilimumab
Nivolumab
Temsirolimus
|
1 |
0 |
Ipilimumab + Nivolumab + TGF-beta-15 peptide vaccine
|
Ipilimumab
Nivolumab
TGF-beta-15 peptide vaccine
|
0 |
1 |
Ipilimumab + Nivolumab + Thymoquinone
|
Ipilimumab
Nivolumab
Thymoquinone
|
0 |
1 |
Ipilimumab + Nivolumab + Tocilizumab
|
Ipilimumab
Nivolumab
Tocilizumab
|
0 |
2 |
Ipilimumab + Nivolumab + TP-1454
|
Ipilimumab
Nivolumab
TP-1454
|
0 |
1 |
Ipilimumab + Nivolumab + Trabectedin
|
Ipilimumab
Nivolumab
Trabectedin
|
0 |
1 |
Ipilimumab + Nivolumab + Trametinib
|
Ipilimumab
Nivolumab
Trametinib
|
0 |
2 |
Ipilimumab + Nivolumab + Trigriluzole
|
Ipilimumab
Nivolumab
Trigriluzole
|
0 |
1 |
Ipilimumab + Nivolumab + UV1 Telomerase peptide vaccine
|
Ipilimumab
Nivolumab
UV1 Telomerase peptide vaccine
|
0 |
1 |
Ipilimumab + Nivolumab + Vedolizumab
|
Ipilimumab
Nivolumab
Vedolizumab
|
0 |
1 |
Ipilimumab + Nivolumab + XL092
|
Ipilimumab
Nivolumab
XL092
|
0 |
1 |
Ipilimumab + Nivolumab + Yttrium-90 microsphere therapy
|
Ipilimumab
Nivolumab
Yttrium-90 microsphere therapy
|
0 |
1 |
Ipilimumab + Nivolumab + ZEN-3694
|
Ipilimumab
Nivolumab
ZEN-3694
|
0 |
1 |
Irinotecan + Nivolumab
|
Irinotecan
Nivolumab
|
0 |
1 |
IRX-2 + Nivolumab
|
IRX-2
Nivolumab
|
0 |
0 |
Ivosidenib + Nivolumab
|
Ivosidenib
Nivolumab
|
0 |
1 |
JNJ-64041757 + Nivolumab
|
JNJ-64041757
Nivolumab
|
0 |
1 |
KYN-175 + Nivolumab
|
KYN-175
Nivolumab
|
0 |
1 |
Lenalidomide + Methotrexate + Nivolumab + Rituximab
|
Lenalidomide
Methotrexate
Nivolumab
Rituximab
|
0 |
1 |
Lenalidomide + Nivolumab
|
Lenalidomide
Nivolumab
|
0 |
4 |
Lenalidomide + Nivolumab + Rituximab
|
Lenalidomide
Nivolumab
Rituximab
|
0 |
1 |
Lenvatinib + Nivolumab
|
Lenvatinib
Nivolumab
|
0 |
1 |
Linrodostat + Nivolumab
|
Linrodostat
Nivolumab
|
0 |
12 |
Linrodostat + Nivolumab + Relatlimab
|
Linrodostat
Nivolumab
Relatlimab
|
0 |
1 |
Linrodostat + Nivolumab + Temozolomide
|
Linrodostat
Nivolumab
Temozolomide
|
0 |
1 |
Lirilumab + Nivolumab
|
Lirilumab
Nivolumab
|
0 |
6 |
Lucitanib + Nivolumab
|
Lucitanib
Nivolumab
|
0 |
2 |
lutetium Lu 177 dotatate + Nivolumab
|
Nivolumab
lutetium Lu 177 dotatate
|
0 |
1 |
Metformin + Nivolumab
|
Metformin
Nivolumab
|
0 |
3 |
Methotrexate + Nivolumab
|
Methotrexate
Nivolumab
|
0 |
1 |
Mivavotinib + Nivolumab
|
Mivavotinib
Nivolumab
|
0 |
1 |
MK-4166 + Nivolumab
|
MK-4166
Nivolumab
|
0 |
1 |
MLN1202 + Nivolumab
|
MLN1202
Nivolumab
|
0 |
1 |
Mocetinostat + Nivolumab
|
Mocetinostat
Nivolumab
|
0 |
1 |
Mogamulizumab + Nivolumab
|
Mogamulizumab
Nivolumab
|
0 |
1 |
Motolimod + Nivolumab
|
Motolimod
Nivolumab
|
0 |
2 |
MT-8421 + Nivolumab
|
MT-8421
Nivolumab
|
0 |
1 |
MTG201 + Nivolumab
|
MTG201
Nivolumab
|
0 |
1 |
MultiTAA-specific T cells + Nivolumab
|
MultiTAA-specific T cells
Nivolumab
|
0 |
1 |
MVA-MUC1-IL2 vaccine + Nivolumab
|
MVA-MUC1-IL2 vaccine
Nivolumab
|
0 |
2 |
MVC-101 + Nivolumab
|
MVC-101
Nivolumab
|
0 |
1 |
Nab-paclitaxel + Nivolumab
|
Nab-paclitaxel
Nivolumab
|
0 |
5 |
Nab-rapamycin + Nivolumab
|
Nab-rapamycin
Nivolumab
|
0 |
1 |
Napabucasin + Nivolumab
|
Napabucasin
Nivolumab
|
0 |
1 |
Nazartinib + Nivolumab
|
Nazartinib
Nivolumab
|
0 |
1 |
Nedaplatin + Nivolumab + Pemetrexed Disodium
|
Nedaplatin
Nivolumab
Pemetrexed Disodium
|
0 |
0 |
Nelfinavir + Nivolumab
|
Nelfinavir
Nivolumab
|
0 |
1 |
NEO-PV-01 + Nivolumab + Poly ICLC
|
NEO-PV-01
Nivolumab
Poly ICLC
|
0 |
1 |
NEO-PV-01 + Nivolumab + Poly ICLC + Sotigalimab
|
NEO-PV-01
Nivolumab
Poly ICLC
Sotigalimab
|
0 |
1 |
NEO212 + Nivolumab
|
NEO212
Nivolumab
|
0 |
1 |
NeoTCR-P1 T-cells + Nivolumab
|
NeoTCR-P1 T-cells
Nivolumab
|
0 |
1 |
NeoVax + Nivolumab
|
NeoVax
Nivolumab
|
0 |
2 |
NeoVax + Nivolumab + Poly ICLC
|
NeoVax
Nivolumab
Poly ICLC
|
0 |
1 |
NG-641 + Nivolumab
|
NG-641
Nivolumab
|
0 |
1 |
Nimotuzumab + Nivolumab
|
Nimotuzumab
Nivolumab
|
0 |
1 |
Niraparib + Nivolumab
|
Niraparib
Nivolumab
|
0 |
1 |
Nivolumab
|
Nivolumab
|
49 |
370 |
Nivolumab + NKTR-214
|
NKTR-214
Nivolumab
|
0 |
10 |
Nivolumab + NKTR-214 + NKTR-262
|
NKTR-214
NKTR-262
Nivolumab
|
0 |
1 |
Nivolumab + NKTR-214 + XL092
|
NKTR-214
Nivolumab
XL092
|
0 |
1 |
Nivolumab + Nogapendekin alfa inbakicept
|
Nivolumab
Nogapendekin alfa inbakicept
|
0 |
2 |
Nivolumab + NT-I7
|
NT-I7
Nivolumab
|
0 |
1 |
Nivolumab + NY-ESO-1 peptide vaccine
|
NY-ESO-1 peptide vaccine
Nivolumab
|
0 |
2 |
Nivolumab + Olaparib
|
Nivolumab
Olaparib
|
0 |
0 |
Nivolumab + Olutasidenib
|
Nivolumab
Olutasidenib
|
0 |
1 |
Nivolumab + ONC201
|
Nivolumab
ONC201
|
0 |
1 |
Nivolumab + OR2805
|
Nivolumab
OR2805
|
0 |
1 |
Nivolumab + OSE 2101
|
Nivolumab
OSE 2101
|
0 |
2 |
Nivolumab + Oxaliplatin
|
Nivolumab
Oxaliplatin
|
0 |
2 |
Nivolumab + Oxaliplatin + Relatlimab + Tegafur-gimeracil-oteracil Potassium
|
Nivolumab
Oxaliplatin
Relatlimab
Tegafur-gimeracil-oteracil Potassium
|
0 |
0 |
Nivolumab + Oxaliplatin + RO7496353 + Tegafur-gimeracil-oteracil Potassium
|
Nivolumab
Oxaliplatin
RO7496353
Tegafur-gimeracil-oteracil Potassium
|
0 |
1 |
Nivolumab + Oxaliplatin + Trifluridine-tipiracil hydrochloride
|
Nivolumab
Oxaliplatin
Trifluridine-tipiracil hydrochloride
|
0 |
1 |
Nivolumab + Paclitaxel
|
Nivolumab
Paclitaxel
|
0 |
5 |
Nivolumab + Paclitaxel + Ramucirumab
|
Nivolumab
Paclitaxel
Ramucirumab
|
0 |
1 |
Nivolumab + Paclitaxel + Relatlimab
|
Nivolumab
Paclitaxel
Relatlimab
|
0 |
1 |
Nivolumab + Pazopanib
|
Nivolumab
Pazopanib
|
0 |
1 |
Nivolumab + PBF-1129
|
Nivolumab
PBF-1129
|
0 |
1 |
Nivolumab + Pegilodecakin
|
Nivolumab
Pegilodecakin
|
0 |
1 |
Nivolumab + Pembrolizumab
|
Nivolumab
Pembrolizumab
|
0 |
2 |
Nivolumab + Pembrolizumab + Trigriluzole
|
Nivolumab
Pembrolizumab
Trigriluzole
|
0 |
1 |
Nivolumab + Pemetrexed Disodium
|
Nivolumab
Pemetrexed Disodium
|
0 |
2 |
Nivolumab + PEP-CMV + Temozolomide
|
Nivolumab
PEP-CMV
Temozolomide
|
0 |
1 |
Nivolumab + Pepinemab
|
Nivolumab
Pepinemab
|
0 |
4 |
Nivolumab + Personalized cancer vaccine + Poly ICLC
|
Nivolumab
Personalized cancer vaccine
Poly ICLC
|
0 |
1 |
Nivolumab + Pexmetinib
|
Nivolumab
Pexmetinib
|
0 |
1 |
Nivolumab + PG545
|
Nivolumab
PG545
|
0 |
1 |
Nivolumab + Plinabulin
|
Nivolumab
Plinabulin
|
0 |
2 |
Nivolumab + Poly ICLC
|
Nivolumab
Poly ICLC
|
0 |
3 |
Nivolumab + Poly ICLC + Rituximab
|
Nivolumab
Poly ICLC
Rituximab
|
0 |
1 |
Nivolumab + Pomalidomide
|
Nivolumab
Pomalidomide
|
0 |
2 |
Nivolumab + PROSTVAC-F-TRICOM + PROSTVAC-V-TRICOM
|
Nivolumab
PROSTVAC-F-TRICOM
PROSTVAC-V-TRICOM
|
0 |
1 |
Nivolumab + PROSTVAC-V-TRICOM
|
Nivolumab
PROSTVAC-V-TRICOM
|
0 |
0 |
Nivolumab + PT2385
|
Nivolumab
PT2385
|
0 |
1 |
Nivolumab + pTVG-HP plasmid DNA vaccine + Sargramostim
|
Nivolumab
Sargramostim
pTVG-HP plasmid DNA vaccine
|
0 |
1 |
Nivolumab + PVSRIPO
|
Nivolumab
PVSRIPO
|
0 |
1 |
Nivolumab + Radium Ra 223 dichloride
|
Nivolumab
Radium Ra 223 dichloride
|
0 |
1 |
Nivolumab + Ramucirumab
|
Nivolumab
Ramucirumab
|
0 |
2 |
Nivolumab + Ramucirumab + Rucaparib
|
Nivolumab
Ramucirumab
Rucaparib
|
0 |
1 |
Nivolumab + Regorafenib
|
Nivolumab
Regorafenib
|
0 |
7 |
Nivolumab + Relatlimab
|
Nivolumab
Relatlimab
|
0 |
41 |
Nivolumab + Relatlimab + rHuPH20
|
Nivolumab
Relatlimab
rHuPH20
|
0 |
2 |
Nivolumab + Relatlimab + Tegafur-gimeracil-oteracil Potassium
|
Nivolumab
Relatlimab
Tegafur-gimeracil-oteracil Potassium
|
0 |
1 |
Nivolumab + RGX-104
|
Nivolumab
RGX-104
|
0 |
1 |
Nivolumab + rhIL-15
|
Nivolumab
rhIL-15
|
0 |
1 |
Nivolumab + rHuPH20
|
Nivolumab
rHuPH20
|
0 |
2 |
Nivolumab + Rigosertib
|
Nivolumab
Rigosertib
|
0 |
1 |
Nivolumab + RiMO-301
|
Nivolumab
RiMO-301
|
0 |
1 |
Nivolumab + Rituximab
|
Nivolumab
Rituximab
|
0 |
1 |
Nivolumab + Rituximab + Venetoclax
|
Nivolumab
Rituximab
Venetoclax
|
0 |
1 |
Nivolumab + Rituximab Hyaluronidase + Venetoclax
|
Nivolumab
Rituximab Hyaluronidase
Venetoclax
|
0 |
0 |
Nivolumab + Rivoceranib
|
Nivolumab
Rivoceranib
|
0 |
1 |
Nivolumab + Rosiglitazone
|
Nivolumab
Rosiglitazone
|
0 |
1 |
Nivolumab + Rovalpituzumab Tesirine
|
Nivolumab
Rovalpituzumab Tesirine
|
0 |
1 |
Nivolumab + RP1
|
Nivolumab
RP1
|
0 |
2 |
Nivolumab + RP2
|
Nivolumab
RP2
|
0 |
2 |
Nivolumab + RP3
|
Nivolumab
RP3
|
0 |
1 |
Nivolumab + Rucaparib
|
Nivolumab
Rucaparib
|
0 |
7 |
Nivolumab + Ruxolitinib
|
Nivolumab
Ruxolitinib
|
0 |
1 |
Nivolumab + RXC004
|
Nivolumab
RXC004
|
0 |
1 |
Nivolumab + Sacituzumab govitecan-hziy
|
Nivolumab
Sacituzumab govitecan-hziy
|
0 |
1 |
Nivolumab + Sargramostim
|
Nivolumab
Sargramostim
|
0 |
1 |
Nivolumab + SB 11285
|
Nivolumab
SB 11285
|
0 |
1 |
Nivolumab + SD-101
|
Nivolumab
SD-101
|
0 |
1 |
Nivolumab + SER-401
|
Nivolumab
SER-401
|
0 |
1 |
Nivolumab + Sitravatinib
|
Nivolumab
Sitravatinib
|
0 |
8 |
Nivolumab + Sorafenib
|
Nivolumab
Sorafenib
|
0 |
1 |
Nivolumab + Sotigalimab
|
Nivolumab
Sotigalimab
|
0 |
2 |
Nivolumab + Sunitinib
|
Nivolumab
Sunitinib
|
0 |
2 |
Nivolumab + SX-682
|
Nivolumab
SX-682
|
0 |
2 |
Nivolumab + SYM004
|
Nivolumab
SYM004
|
0 |
1 |
Nivolumab + Tadalafil
|
Nivolumab
Tadalafil
|
0 |
1 |
Nivolumab + Tadalafil + Vancomycin
|
Nivolumab
Tadalafil
Vancomycin
|
0 |
1 |
Nivolumab + Talazoparib
|
Nivolumab
Talazoparib
|
0 |
1 |
Nivolumab + Talimogene laherparepvec
|
Nivolumab
Talimogene laherparepvec
|
0 |
2 |
Nivolumab + Talimogene laherparepvec + Trabectedin
|
Nivolumab
Talimogene laherparepvec
Trabectedin
|
0 |
1 |
Nivolumab + Tavokinogene telseplasmid
|
Nivolumab
Tavokinogene telseplasmid
|
0 |
1 |
Nivolumab + Tegafur-gimeracil-oteracil Potassium
|
Nivolumab
Tegafur-gimeracil-oteracil Potassium
|
0 |
1 |
Nivolumab + Telaglenastat
|
Nivolumab
Telaglenastat
|
0 |
1 |
Nivolumab + Temozolomide
|
Nivolumab
Temozolomide
|
0 |
5 |
Nivolumab + Tesetaxel
|
Nivolumab
Tesetaxel
|
0 |
1 |
Nivolumab + Testosterone cypionate
|
Nivolumab
Testosterone cypionate
|
0 |
1 |
Nivolumab + Tivozanib
|
Nivolumab
Tivozanib
|
0 |
2 |
Nivolumab + Tocilizumab
|
Nivolumab
Tocilizumab
|
0 |
1 |
Nivolumab + Tovorafenib
|
Nivolumab
Tovorafenib
|
0 |
2 |
Nivolumab + TPST-1120
|
Nivolumab
TPST-1120
|
0 |
1 |
Nivolumab + Trametinib
|
Nivolumab
Trametinib
|
0 |
3 |
Nivolumab + Trastuzumab deruxtecan
|
Nivolumab
Trastuzumab deruxtecan
|
0 |
2 |
Nivolumab + Trifluridine-tipiracil hydrochloride
|
Nivolumab
Trifluridine-tipiracil hydrochloride
|
0 |
1 |
Nivolumab + TRK-950
|
Nivolumab
TRK-950
|
0 |
1 |
Nivolumab + TRX518
|
Nivolumab
TRX518
|
0 |
0 |
Nivolumab + UCPVax
|
Nivolumab
UCPVax
|
0 |
1 |
Nivolumab + Urelumab
|
Nivolumab
Urelumab
|
0 |
5 |
Nivolumab + Valproic acid
|
Nivolumab
Valproic acid
|
0 |
1 |
Nivolumab + Vancomycin + VE800
|
Nivolumab
VE800
Vancomycin
|
0 |
1 |
Nivolumab + Varlilumab
|
Nivolumab
Varlilumab
|
0 |
3 |
Nivolumab + VB-111
|
Nivolumab
VB-111
|
0 |
1 |
Nivolumab + Veliparib
|
Nivolumab
Veliparib
|
0 |
1 |
Nivolumab + VG161
|
Nivolumab
VG161
|
0 |
1 |
Nivolumab + Vidutolimod
|
Nivolumab
Vidutolimod
|
0 |
5 |
Nivolumab + Vinblastine
|
Nivolumab
Vinblastine
|
0 |
1 |
Nivolumab + Vopratelimab
|
Nivolumab
Vopratelimab
|
0 |
2 |
Nivolumab + Vorolanib
|
Nivolumab
Vorolanib
|
0 |
2 |
Nivolumab + WT1 vaccine
|
Nivolumab
WT1 vaccine
|
0 |
1 |
Nivolumab + X4P-001
|
Nivolumab
X4P-001
|
0 |
1 |
Nivolumab + XB002
|
Nivolumab
XB002
|
0 |
1 |
Nivolumab + Xevinapant
|
Nivolumab
Xevinapant
|
0 |
1 |
Nivolumab + XL092
|
Nivolumab
XL092
|
0 |
2 |
Nivolumab + Yttrium-90 microsphere therapy
|
Nivolumab
Yttrium-90 microsphere therapy
|
0 |
1 |
Nivolumab + ZEN-3694
|
Nivolumab
ZEN-3694
|
0 |
1 |